SCHEMBL7525761

SCHEMBL7525761

CC(C)(C)c1cc2c(c(C(C)(C)C)c1O)CC(Cc1ccccc1)(Cc1ccccc1)S2

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ MAOB P27338 7/20 0.32
▸ TSHR P16473 2/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ TNFRSF1A P19438 1/20 0.32
▸ MAOA P21397 4/20 0.31
▸ BCHE P06276 2/20 0.31
▸ ACHE P22303 2/20 0.31
▸ ALOX5 P09917 1/20 0.31
▸ PTGS1 P23219 1/20 0.31
▸ PTGS2 P35354 1/20 0.31
▸ F2R P25116 1/20 0.31
▸ TACR3 P29371 1/20 0.30
▸ ALDH1A1 P00352 1/20 0.30
▸ LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7524824 0.82 CA2 (0.33) GAAMEN1KMT2ATSHRCYP1A2
SCHEMBL7523511 0.81 CA2 (0.33) GAATSHRPTGS1PTGS2ALDH1A1
SCHEMBL7521635 0.80 NR5A2 (0.33) PTGS1PTGS2ALDH1A1LMNA
SCHEMBL7523629 0.79 MEN1 (0.35) GAAMEN1KMT2ATSHRCYP1A2
SCHEMBL6130759 0.79 NR5A2 (0.32) PTGS2ALDH1A1
SCHEMBL7519511 0.78 NR5A2 (0.32) F2RALDH1A1
SCHEMBL7525491 0.78 NR5A2 (0.32) F2RALDH1A1
SCHEMBL7520082 0.78 NR5A2 (0.32) F2RALDH1A1
SCHEMBL7527616 0.77 — —
SCHEMBL6308900 0.74 CA2 (0.40) MEN1KMT2ACYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6440999-B1 Intimal thickening inhibitory agent CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2002-08-27 — — US disclosed
EP-0791589-B1 4,6-DI-t-BUTYL-2,3-DIHYDROBENZOTHIOPHENES WHICH INHIBIT LDL OXIDATION CHUGAI PHARMACEUTICAL CO LTD (JP) 2002-03-06 — — EP disclosed
CN-1073563-C 4, 6-di-tert-butyl-2, 3-dihydrobenzothiophene derivatives CHUGAI PHARMACEUTICAL CO LTD (JP) 2001-10-24 — — CN disclosed
US-6133279-A A 2,6-DI-T-BUTYLPHENOL DERIVATIVE FOR RENAL DISEASES, E.G., CHRONIC RENAL FAILURE, DIABETIC NEPHROPATHY GLOMERULAR NEPHRITIS, IMMUNOCOMPLEX NEPHRITIS AND ACUTE RENAL FAILURE; CYTOPROTECTIVE AGENT THAT INHIBITS THE LIPID PEROXIDATION CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2000-10-17 — — US disclosed
US-6103753-A ADMINISTERING TO A PATIENT FOR INHIBITING THICKENING OF VASCULAR STENOSIS FOLLOWING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY, A 2,6-DI-T-BUTYLPHENOL DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2000-08-15 — — US disclosed
EP-0950405-A1 REMEDIES FOR RENAL DISEASES AND ORGAN-PRESERVING AGENTS CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 1999-10-20 — — EP disclosed
CN-1204259-A Intimal thickening inhibitor SHONAN KIKO K K (JP) 1999-01-06 — — CN disclosed
EP-0868913-A1 INTIMAL THICKENING INHIBITOR Chugai Seiyaku Kabushiki Kaisha (JP) 1998-10-07 — — EP disclosed
US-5789436-A ARTERIOSCLEROSIS; INHIBITORS OF OXIDATION OF LOW DENSITY LIPOPROTEINS; CHUGAI SEIYAK KABUSHIKI KAISHA (JP) 1998-08-04 — — US disclosed
EP-0791589-A1 4,6-DI-t-BUTYL-2,3-DIHYDROBENZOTHIOPHENES WHICH INHIBIT LDL OXIDATION CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 1997-08-27 — — EP disclosed
CN-1148386-A 4,6-di-5-butyl-2,3-dihydrobenzothiophene derivative CHUGAI PHARMACEUTICAL CO LTD (JP) 1997-04-23 — — CN disclosed
Send feedback